Blood cell separation
OwnerNeil David Avent, Zoe Eileen Plummer +1inventors
InventorsNeil David Avent, Zoe Eileen Plummer, David John Head
Life of this patent
Estimating the term…
Loading patent…
OwnerNeil David Avent, Zoe Eileen Plummer +1inventors
InventorsNeil David Avent, Zoe Eileen Plummer, David John Head
Estimating the term…
There is provided a method of isolating foetal cells from an isolated sample of maternal blood, the method comprising identifying cells having a different expression pattern of at least one foetal marker compared to the expression pattern of the marker in an equivalent maternal cell and selecting the identified cells, characterised in that the foetal marker is selected from: HSP-60, a monoamine oxidase, glutamine synthase, Ara-70, Ara-54, FLJ20202, DCN-I protein, RAB5A, HSP-7C, EF1A1, GRP78, MYL4, DnaJ homolog subfamily B member 14, Vinculin, Desmoplakin, AMMECR1-like protein, Extracellular matrix protein 2 precursor protein, uncharacterised protein Cxorf57, Peroxiredoxin 1, Peroxiredoxin 2. There is also provided a method of cultivating foetal cells and a foetal cell isolation kit.
A method of isolating foetal cells from a sample of maternal blood, the method comprising:
A method of isolating foetal cells from maternal blood, the method comprising:
A method of cultivating foetal cells, the method comprising:
(canceled)
A foetal cell isolation kit, comprising:
(canceled)
(canceled)
An apparatus comprising:
A method of determining that a cell is a foetal cell, the method comprising:
Dependencies are inferred from the claim text.